KADMON HOLDINGS, INC.
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 89.46B | ||||||
| 40.74B | ||||||
| 33.03B | ||||||
| 24.68B | ||||||
| 15.12B |
